Chemed (FRA:CXM) Total Current Assets: €237 Mil (As of Mar. 2026)

Chemed FRA:CXM -0.99% 72 Total Current Assets is €237 Mil as of Mar. 2026. GuruFocus rates FRA:CXM with a GF Score™ of 72/100 and a GF Value™ of €567.34 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Chemed's total current assets for the quarter that ended in Mar. 2026 was €237 Mil.

Chemed (FRA:CXM) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Chemed's Liquidation Value for the quarter that ended in Mar. 2026 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	14.58	-	594.965	+	0.75 * 186.389	+	0.5 * 6.235
=	-437

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemed Total Current Assets Related Terms

Chemed Total Current Assets Historical Data

* Premium members only.

The historical data trend for Chemed's Total Current Assets can be seen below:

Chemed Total Current Assets Chart

Chemed Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Current Assets

Get a 7-Day Free Trial

203.80

257.35

459.27

376.98

258.43

Chemed Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Current Assets	Get a 7-Day Free Trial															464.71	426.02	336.75	258.43	237.06

72GF Score

Chemed Corp FRA:CXM

Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Chemed Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Chemed's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	63.636	+	155.919	+	6.442	+	32.437
	=	258

Chemed's Total Current Assets for the quarter that ended in Mar. 2026 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	14.58	+	186.389	+	6.235	+	29.86
	=	237

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →

What does a Total Current Assets of €237 Mil mean?

Chemed (FRA:CXM) has a Total Current Assets of €237 Mil as of Mar. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Chemed and its competitors.

Is Chemed's Total Current Assets too high?

Chemed's current Total Current Assets is €237 Mil. Overall, Chemed has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Chemed's Total Current Assets compare to PACS and LFST?

Chemed's Total Current Assets of €237 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Current Assets for a Healthcare Providers & Services company?

A good Total Current Assets depends on the Healthcare Providers & Services industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Current Assets mean?

A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Chemed and its competitors. Chemed's current Total Current Assets is €237 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Chemed stock overvalued right now?

Based on GuruFocus' analysis, Chemed (FRA:CXM) is currently considered Modestly Undervalued. The stock's GF Value™ is €567.34, compared to a current price of €400.00 — trading 29.5% below its estimated fair value. The current Total Current Assets is €237 Mil. Chemed's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Current Assets calculated?

Total Current Assets is calculated from a company's financial statements. For Chemed (FRA:CXM), the current Total Current Assets is €237 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemed (FRA:CXM) Overvalued in 2026?

Based on GuruFocus' analysis, Chemed stock appears to be undervalued. The current stock price of €400.00 is trading 29.5% below its estimated GF Value™ of €567.34. GuruFocus considers Chemed to be Modestly Undervalued.

Key valuation signals for FRA:CXM:

Total Current Assets: €237 Mil
GF Value™: €567.34 vs. price of €400.00 (29.5% below fair value)
GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the FRA:CXM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chemed Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies PACS LFST CON BKD UHS OPCH NHC ENSG GRDN ACHC HCA XTER:FRE SAU:4013 XKLS:5225 THC BSP:RDOR3 DVA NSE:APOLLOHOSP XTER:FME BOM:543220

Other Exchanges CHE:USA

Address 255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726

Website https://www.chemed.com

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

72GF Score

Get the complete analysis for FRA:CXM

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€400.00

Price

€567.34

GF Value

View FRA:CXM Analysis

See Total Current Assets data for all stocks →